Brian Casey

Home
AuntMinnie.com Digital X-Ray Insider
December 18, 2019
PACS/VNA
Hitachi board votes to sell medical division to Fujifilm
The board of directors of Japanese industrial conglomerate Hitachi has voted to sell its Hitachi Medical division to Fujifilm for a total price of 179 billion yen ($1.63 billion). The deal will combine two second-tier players in the radiology industry to create a firm that could compete with the largest multimodality vendors.
December 17, 2019
2019 11 01 17 15 4122 Graph Financial Results Skyscraper 400
PACS/VNA
Report: Fujifilm plans to buy Hitachi imaging business
Fujifilm is planning to acquire the medical imaging business of Hitachi in what would be a major consolidation of Japanese medical device firms, according to news reports. The deal would marry Fujifilm's strength in digital x-ray and image management software with Hitachi's modality scanner business.
December 16, 2019
2019 11 13 00 46 2926 Business Deal Corporate 400
Home
Week in Review: VA reviews imaging delays | CTA overuse? | Digital mammo's edge
December 13, 2019
Practice Management
Massive VHA audit explores reasons for imaging delays
A massive review of outpatient radiology and nuclear medicine services in the U.S. Veterans Health Administration (VHA) found that 17% of routine requests and 25% of urgent orders for outpatient imaging were not performed in a timely fashion.
December 9, 2019
2019 12 09 17 23 7420 Veterans Affairs Va Seal 400
Home
Week in Review: AI again dominates at RSNA | Imaging of vaping | MRI safety
December 6, 2019
Molecular Imaging
United Imaging launches mobile PET/CT unit at RSNA 2019
CHICAGO - United Imaging Healthcare is marking its second RSNA meeting as an exhibitor by launching a new mobile digital PET/CT scanner, UMI 550. The company is also debuting an ultrawide-bore 3-tesla MRI scanner and is showcasing products that have received regulatory clearance since last year's meeting.
December 1, 2019
2018 12 21 22 34 2777 United Imaging Rsna 2018 400
Home
RSNA 2019: The human connection | New studies on AI | Trends in Imaging Informatics
November 30, 2019
Molecular Imaging
Canon launches spectral CT, digital PET/CT at RSNA
CHICAGO - A new wide-area spectral CT scanner with data reconstruction based on artificial intelligence, a new fully digital PET/CT scanner, and enhancements in ultrasound, MRI, and interventional imaging are among the highlights in the RSNA 2019 booth of Canon Medical Systems USA.
November 30, 2019
2019 12 01 18 22 2619 Canon Cartesion Prime Petct 20191201202437
Image-Guided Surgery
Focused ultrasound treatment to brain relieves tremors
Applying treatments of MR-guided focused ultrasound to the brain can be an effective therapy for people with essential tremor, as well as tremor related to Parkinson's disease, according to a study to be presented at RSNA 2019 in Chicago.
November 25, 2019
2019 11 25 23 51 7600 Rsna Grand Concourse 400
Previous Page
Page 29 of 140
Next Page
Top Stories
2026 02 12 Chest Ac2 Thumbnail
Digital X-Ray
Chest x-rays reveal atherosclerosis in patients undergoing amputations
Lower limb amputation is an increasingly common major complication of advanced peripheral arterial disease and diabetes mellitus.
Cardiac Mri Adobe Samunella
MRI
3D MRI technique helps plan treatment for pediatric heart conditions
Images of a 39-year-old who underwent screening mammography. Right craniocaudal (left) and mediolateral oblique (middle) views from preoperative mammography show suspicious grouped fine pleomorphic calcifications (arrows). After biopsy showed ductal carcinoma of situ (DCIS), patient underwent breast-conserving surgery, yielding final diagnosis of ductal carcinoma in situ (intermediate grade, hormone receptor positive). (Right) Screenshot of an output of a commercial AI tool applied to preoperative mammography. AI detected right breast lesion with score of 95% on both views (concentric colored circles). Present study’s reviewing radiologist deemed AI marking to correspond with site of DCIS.
Womens Imaging
Could AI scoring help with managing DCIS?
Axial contrast-enhanced CT scan in a 28-year-old premenopausal woman shows an incidentally detected solid-appearing left ovarian lesion (solid arrow) anterior to the uterus (U), associated with trace ascites in the right adnexa and cul de sac (dashed arrows). At pathologic analysis, this was shown to be ovarian dysgerminoma. Two readers misdiagnosed this lesion, one as a leiomyoma and one as an ovarian fibroma.
CT
Clinicians, beware: CT diagnostic accuracy varies by adnexal lesion type
Erin Stephens
Practice Management
Radiology coding update for 2026
More in Home
ASTRO: Proton therapy shows promise in breast cancer treatment
By Amerigo Allegretto
Proton radiation achieves similar health-related quality of life measures compared to photon radiation in breast cancer patients.
September 30, 2025
Img 2757
Israeli radiologist discusses response to Oct. 7 attacks
By Will Morton
Workflow and staffing changes led to a reduction in CT turnaround times from 54 minutes to 27 minutes after the October 7, 2023 attack.
September 30, 2025
Representative injuries in patients from the mass casualty incident of October 7, 2023. (A) Axial CT scan at the pelvic level in a 34-year-old male patient shows multiple shrapnel fragments in the pelvis, resulting in fractures of the pelvic bones and lumbar vertebrae (not visible on this image). (B) Coronal reconstruction of a head CT scan in a 20-year-old male patient shows penetrating trauma to the left eyeball with a retained bullet in the orbital cavity. (C) Radiograph of a fetus delivered by emergency cesarean section from a critically injured mother shows a left pneumothorax and catheter in place. (D) Radiograph in a 25-year-old female patient shows a comminuted fracture in the tibial metaphysis with fragment displacement and multiple bony fragments in the surrounding soft tissues.
ASTRO: Trial suggests postoperative RT in high-risk bladder cancer
By Liz Carey
Moderate doses of radiation therapy (RT) after bladder removal surgery cut rates of new pelvic cancer, according to researchers.
September 30, 2025
Moscone Center Astro
ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression
By Will Morton
Two cycles of lutetium-177 PNT2002 before stereotactic body radiation therapy (SBRT) significantly improved progression-free survival.
September 29, 2025
Moscone Center Astro
ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer
By Liz Carey
Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.
September 29, 2025
Moscone Center Astro
NAPT survey results show promise for proton therapy adoption
By Amerigo Allegretto
Proton therapy continues to experience increased clinical use, but barriers to care continue to limit its potential.
September 29, 2025
Survey Form 400
ASTRO: Low-dose RT effective for treating knee osteoarthritis
By Amerigo Allegretto
Research presented at ASTRO 2025 showed the effectiveness of low-dose radiation therapy for treating knee osteoarthritis.
September 29, 2025
Moscone Center Astro
ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer
By Will Morton
Patients with a prostate tumor subtype known as luminal B had meaningful benefits from the addition of apalutamide to secondary radiotherapy.
September 29, 2025
Moscone Center Astro
ASTRO: Patient navigation key to mitigating RT treatment disparities
By Kate Madden Yee
"Patients are lost and need to be navigated," said presenter Christina Chapman, MD, of Baylor College of Medicine in Houston.
September 29, 2025
Moscone Center Astro
ASTRO: Radiotherapy offers opportunities beyond cancer treatment
By Kate Madden Yee
Radiotherapy isn't just for cancer treatment, according to talks at ASTRO 2025 in San Francisco.
September 28, 2025
Moscone Center Astro
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
New brain MRI technique could help identify Alzheimer's
By Kate Madden Yee
Researchers used 7-tesla MRI to demonstrate how microvessel pulses in the brain's deep white matter increase with age.
September 26, 2025
Mri Head
Previous Page
Page 29 of 202
Next Page